leisure time -WSS

leisure time

author：Wikipedia 2025-08-25 16:25:40 - browse：8743

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： FDA panel endorses Alnylam’s heart drug — after picking it apart

knowledge

WSS

How medical schools plan to diversify without affirmative action

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What we need to know about Arena Bioworks

Covid misinformation case heads to Supreme Court

Cognito secures funding to test medical device for Alzheimer's

SAMSHA loosens regulations on methadone treatment centers

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

FDA panel endorses Alnylam’s heart drug — after picking it apart

How to save PrEP access — and even expand it

New weight loss drugs vying to be the next Wegovy or Mounjaro

Wildfire smoke exposes gaps in outdoor worker protections

FDA proposes changes to key medical devices approval pathway

State Dept. review finds Biden bears some blame for Afghanistan failures

Do digital therapeutics have a future in medicine?

At least 13 dead in Texas as scorching temps continue

Hospitals consider fixing cancer drug shortages on their own

focus

Novo Nordisk to expand supply of Wegovy for U.S. patients

Juul spent big to court Black leaders to promote its e

FDA drug safety: Singulair case shows systemic surveillance flaws

How housing is health care on Long Island

What to make of Biden’s latest efforts on cancer research

How housing is health care on Long Island

knowledge

focus

entertainment

Wikipedia